Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Subject: Heart Disease - PUBLISHED VIA American Journal of Physiology
Author(s):
Durst R, Danenberg H, Gallily R, Mechoulam R, Meir K, Grad E, Beeri R, Pugatsch T, Tarsish E, Lotan C
View Source >>
Related Studies:
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
Published via Journal of Cardiovascular Pharmacology and Therapeutics
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Published via British Journal of Pharmacology
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Published via Author Manuscript
Is the cardiovascular system a therapeutic target for cannabidiol?
Published via British Pharmacological Society
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors
Published via BMJ Publishing Group Limited